Molecular NeuroImaging (MNI) is now Invicro.

In 2016, MNI (Molecular NeuroImaging) was acquired by Invicro and now operates as a wholly owned subsidiary of Invicro. Clinical capabilities have been fully integrated into our workflow, and with a team of over 200 employees we provide the most comprehensive set of imaging services across the spectrum of drug development. Read more here.

Invicro Home | Careers | Contact Us | Clinical Imaging 

Molecular NeuroImaging


Share this page: